These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7868850)

  • 1. Adjunctive fluoxetine in the treatment of negative symptoms in chronic schizophrenic patients.
    Spina E; De Domenico P; Ruello C; Longobardo N; Gitto C; Ancione M; Di Rosa AE; Caputi AP
    Int Clin Psychopharmacol; 1994; 9(4):281-5. PubMed ID: 7868850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoxetine augmentation of clozapine treatment in patients with schizophrenia.
    Buchanan RW; Kirkpatrick B; Bryant N; Ball P; Breier A
    Am J Psychiatry; 1996 Dec; 153(12):1625-7. PubMed ID: 8942462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoxetine as an adjunct to conventional antipsychotic treatment of schizophrenia patients with residual symptoms.
    Arango C; Kirkpatrick B; Buchanan RW
    J Nerv Ment Dis; 2000 Jan; 188(1):50-3. PubMed ID: 10665462
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjunctive nadolol in the treatment of acutely aggressive schizophrenic patients.
    Allan ER; Alpert M; Sison CE; Citrome L; Laury G; Berman I
    J Clin Psychiatry; 1996 Oct; 57(10):455-9. PubMed ID: 8909331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.
    Small JG; Hirsch SR; Arvanitis LA; Miller BG; Link CG
    Arch Gen Psychiatry; 1997 Jun; 54(6):549-57. PubMed ID: 9193196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A placebo-controlled trial of fluoxetine added to neuroleptic in patients with schizophrenia.
    Goff DC; Midha KK; Sarid-Segal O; Hubbard JW; Amico E
    Psychopharmacology (Berl); 1995 Feb; 117(4):417-23. PubMed ID: 7604142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of clozapine and adjunctive high-dose glycine in treatment-resistant schizophrenia.
    Potkin SG; Jin Y; Bunney BG; Costa J; Gulasekaram B
    Am J Psychiatry; 1999 Jan; 156(1):145-7. PubMed ID: 9892314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyproheptadine in treatment-resistant chronic schizophrenics with prior negative response to fluoxetine.
    Bacher NM; Sanzone MM; Kaup B
    J Clin Psychopharmacol; 1994 Dec; 14(6):424-5. PubMed ID: 7884024
    [No Abstract]   [Full Text] [Related]  

  • 9. Antidepressants in 'depressed' schizophrenic inpatients. A controlled trial.
    Kramer MS; Vogel WH; DiJohnson C; Dewey DA; Sheves P; Cavicchia S; Little P; Schmidt R; Kimes I
    Arch Gen Psychiatry; 1989 Oct; 46(10):922-8. PubMed ID: 2679483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of a selective D4 dopamine receptor antagonist (L-745,870) in acutely psychotic inpatients with schizophrenia. D4 Dopamine Antagonist Group.
    Kramer MS; Last B; Getson A; Reines SA
    Arch Gen Psychiatry; 1997 Jun; 54(6):567-72. PubMed ID: 9193198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trial of fluoxetine added to neuroleptics for treatment-resistant schizophrenic patients.
    Goff DC; Brotman AW; Waites M; McCormick S
    Am J Psychiatry; 1990 Apr; 147(4):492-4. PubMed ID: 1969245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine.
    de Lucena D; Fernandes BS; Berk M; Dodd S; Medeiros DW; Pedrini M; Kunz M; Gomes FA; Giglio LF; Lobato MI; Belmonte-de-Abreu PS; Gama CS
    J Clin Psychiatry; 2009 Oct; 70(10):1416-23. PubMed ID: 19906345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of schizophrenic patients with primary negative symptoms treated with amisulpride. Amisulpride Study Group.
    Danion JM; Rein W; Fleurot O
    Am J Psychiatry; 1999 Apr; 156(4):610-6. PubMed ID: 10200742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: efficacy and safety.
    Anil Yağcioğlu AE; Kivircik Akdede BB; Turgut TI; Tümüklü M; Yazici MK; Alptekin K; Ertuğrul A; Jayathilake K; Göğüş A; Tunca Z; Meltzer HY
    J Clin Psychiatry; 2005 Jan; 66(1):63-72. PubMed ID: 15669890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjunctive fluoxetine improves global function in chronic schizophrenia.
    Goldman MB; Janecek HM
    J Neuropsychiatry Clin Neurosci; 1990; 2(4):429-31. PubMed ID: 1983785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: a placebo-controlled trial.
    Shim JC; Shin JG; Kelly DL; Jung DU; Seo YS; Liu KH; Shon JH; Conley RR
    Am J Psychiatry; 2007 Sep; 164(9):1404-10. PubMed ID: 17728426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risperidone in the treatment of schizophrenia.
    Marder SR; Meibach RC
    Am J Psychiatry; 1994 Jun; 151(6):825-35. PubMed ID: 7514366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia: a randomized, double-blind, placebo-controlled study.
    Lane HY; Chang YC; Liu YC; Chiu CC; Tsai GE
    Arch Gen Psychiatry; 2005 Nov; 62(11):1196-204. PubMed ID: 16275807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia.
    Strous RD; Maayan R; Lapidus R; Stryjer R; Lustig M; Kotler M; Weizman A
    Arch Gen Psychiatry; 2003 Feb; 60(2):133-41. PubMed ID: 12578430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placebo-controlled, double-blind study of the effects of proglumide in the treatment of schizophrenia.
    Whiteford HA; Stedman TJ; Welham J; Csernansky JG; Pond SM
    J Clin Psychopharmacol; 1992 Oct; 12(5):337-40. PubMed ID: 1362205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.